Populära orter

Populära kategorier

Företagsregister

CSL Behring AB

homepage

logo

mobile_slideshow

company_description

cover_photo

Products for the treatment of Congenital FXIII Deficiency, Congenital Fibrinogen Deficiency, Haemophilia, Rapid Warfarin Reversal and von Willebrand Disease.

Bleeding disorders

Products for the treatment of Immune Deficiency Disorders and Haemolytic Disease of the Newborn

Immunology

Products for the treatment of Hypovolaemic Shock, Perioperative Prophylaxis of Bleedings and Hereditary Angioedema

Critical Care

CSL Behring is committed to saving lives and improving the quality of life for people with rare and serious diseases, worldwide. #nl# #nl#We trace our corporate roots back to Emil von Behring, an innovator within serum therapies who won the first Nobel Prize in Physiology and Medicine. Innovation remains a core value of the company today. #nl# #nl#CSL Behring’s comprehensive line of therapies includes: #nl# #nl# #nl#Plasma-derived and recombinant coagulation factors for the treatment of hemophilia, von Willebrand disease and other bleeding disorders #nl# #nl# #nl#Immunoglobulins for the treatment of primary immune deficiency (PID), idiopathic thrombocytopenic purpura (ITP), Guillain-Barré Syndrome (GBS) and other disorders #nl# #nl# #nl#Immunoglobulins for the prevention of hemolytic disease of the newborn #nl# #nl# #nl#Alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy in adult Alpha-1 patients with emphysema #nl# #nl# #nl#Immunoglobulins for the prevention of cytomegalovirus infection (CMV) in organ transplantation #nl# #nl# #nl#C1-INH concentrate, a plasma-derived intravenous therapy containing the protein that is missing or defective in patients with hereditary angioedema #nl# #nl# #nl#Treatments that inhibit the formation of blood clots #nl# #nl# #nl#Wound-healing agents used during major surgical procedures #nl# #nl# #nl#Albumin for the treatment of burns, shock, and circulatory disorders #nl# #nl#Our products are produced at facilities in Bern, Switzerland; Marburg, Germany; Kankakee, Illinois,USA; and Broadmeadows, Australia, in accordance with international safety and quality standards. The company also operates CSL Plasma, one of the world’s largest plasma collection networks throughout the United States and Germany. CSL Behring has 14,000+ employees worldwide who provide our lifesaving therapies to patients in 60 countries. #nl# #nl#We are passionate about safety, quality and the customers we serve. Our extensive research and development and range of support services demonstrate our ongoing commitment to all who count on our products.

About CSL Behring

free_text

complimentary_ranking

extra_image

Sedana Medical AB

Evolan Pharma AB

Ortivus Mobimed, AB

Avia Pharma AB

Medlase Nordics AB

GE Healthcare Sverige AB

facebook

B. Braun Medical AB

email

Applied Innovation Management In Sweden AB

Deteden AB

Qatine, Mohammed

Svea Medicare AB

Erbe Sweden AB

Hipra Nordic Aps Filial

Z Hygiene Nordic AB

GE Healthcare AB

Kinchard AB

Lablife Nordic Diagnostics AB

Ilenio AB

Tibi Pharma AB

Inari Medical Europe Gmbh Filial

CardioNord AB

Holmsvanen Tf AB

Mistr Sweden AB

Onemed Sverige AB